Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Breast Neoplasms 2 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1

Interventions

Cisplatin 47 Radiotherapy 37 Fluorouracil 23 Cetuximab 17 pembrolizumab 11 Carboplatin 11 Paclitaxel 8 Docetaxel 8 Radiotherapy, Intensity-Modulated 6 Chemotherapy, Adjuvant 6 Surgical Procedures, Operative 5 Standard of Care 5 nimotuzumab 4 Methotrexate 4 Gabapentin 4 Drug Therapy 4 Afatinib 4 Radiotherapy, Conformal 3 Radiation 3 Porfiromycin 3 Nivolumab 3 Neoadjuvant Therapy 3 Fibroblast Growth Factor 7 3 Bleomycin 3 zalutumumab 2 sargramostim 2 epacadostat 2 Tranexamic Acid 2 Tirapazamine 2 Pilocarpine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Head and Neck Neoplasms × NVP-BKM120 × Clear all

NCT04338399 2025-11-17

BURAN

Adlai Nortye Biopharma Co., Ltd.

Phase 3 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡